Talk:Bremelanotide

Wiki Education Foundation-supported course assignment
This article was the subject of a Wiki Education Foundation-supported course assignment, between 3 September 2019 and 12 December 2019. Further details are available on the course page. Student editor(s): Sdavid5304.

Above undated message substituted from Template:Dashboard.wikiedu.org assignment by PrimeBOT (talk) 16:14, 16 January 2022 (UTC)

Palatin Technologies
Should Palatin Technologies have it's own article? It just redirects here now for some reason, I guess this their closest product to market. Endercase (talk) 18:14, 6 April 2017 (UTC)
 * I kind of doubt whether they are really notable enough to have their own article. but if somebody wants to try, they can find out. Jytdog (talk) 20:10, 6 April 2017 (UTC)

Placebo. Daily sex?
https://www.livescience.com/65784-how-womens-libido-drug-works.html

(25-17=8%, so could this medicine be replaced by placebo?)
 * 25% of those who took bremelanotide saw some improvements in their reported sexual desire scores, compared with 17% who took a placebo.

(What if the partner wishes to have sex daily, not 8 times a month?)
 * Women should not take more than one dose of bremelanotide within a 24-hour period or more than 8 doses per MONTH.

--ee1518 (talk) 15:46, 12 August 2019 (UTC)

"Palatin Technologies" listed at Redirects for discussion
The redirect [//en.wikipedia.org/w/index.php?title=Palatin_Technologies&redirect=no Palatin Technologies] has been listed at redirects for discussion to determine whether its use and function meets the redirect guidelines. Readers of this page are welcome to comment on this redirect at  until a consensus is reached. (t &#183; c)  buidhe  06:10, 4 December 2023 (UTC)